Abstract
Medication overuse or rebound headache (MOH) is a secondary chronic daily headache (CDH), defined by a worsening and transformation of episodic migraine into daily or near-daily headache, associated with overuse of acute anti-migraine medications. The frequency at which acute medication results in MOH varies, and can be as little as 5 days of use per month for butalbital, 8 days per month for narcotics, and 10 days per month for triptans and NSAIDs.
Prevention of MOH is encouraged by using headache diaries to keep number of headache days per month low with optimal use of acute medications, and intervention with preventive medications when appropriate. Treatment of MOH is predicated on absolute wean of overused medications, establishing prophylaxis, providing migraine-specific acute medications with limits, and behavioral and educational interventions and therapies. Limiting acute medication use to 2 days per week is a prudent first step.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004;62:788–90.
Lake 3rd AE, Saper JR, Hamel RL. Comprehensive inpatient treatment of refractory chronic daily headache. Headache. 2009;49:555–62.
Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. Stratified care vs. step care strategies for migraine. The disability in strategies of care (DISC) study. JAMA. 2000;284:2599–605.
Loder E, Biondi D. Oral phenobarbital loading: a safe and effective method of withdrawing patients with headache from butalbital compounds. Headache. 2003;43:904–9.
Mathew NT, Kurman R, Perez F. Drug induced refractory headache – clinical features and management. Headache. 1990;30:634–8.
Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995–7.
Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.
Sheftell FD, Brunton SA, Coon TL, Hutchinson SL, Kaniecki RG. Chronic daily headache: understanding and treating a common malady. Fam Pract Recert. 2004;6:25–36.
Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother. 1999;33:61–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tepper, S.J., Tepper, D.E. (2011). Treatment of Medication Overuse Headache. In: Tepper, S.J., Tepper, D.E. (eds) The Cleveland Clinic Manual of Headache Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0179-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0179-7_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0178-0
Online ISBN: 978-1-4614-0179-7
eBook Packages: MedicineMedicine (R0)